Abstract
Method VOCs were measured in thirty-three asthmatic children (age: 11.8 yrs, SD 2.3 yrs) who participated in the PACMAN2 study. All children were current users of ICS. Current asthma control was assessed using the Asthma Control Questionnaire. Long-term asthma control was based on reported symptoms in the four seasons preceding baseline and follow-up visit. A single vital capacity volume of exhaled air was collected upon 5 minutes of normal breathing through a three-way non-re-breathing valve with a VOC filter in a Tedlar bag. The VOCs in the breath sample were subsequently captured on Tenax GR Tubes and analyzed offline on a validated panel of four eNoses with different sensor technologies (Owlstone Lonestar, Sensigent Cyranose 320, Comon Invent eNose and Tor Vergata TEN). Breathprints were analysed per eNose using principal component analyses (PCA). ROC curves and cross-validated accuracy values of significant (t-test) principal components were used to assess the accuracy of the devices to discriminate between controlled and uncontrolled patients. Additionally, the fraction of exhaled nitric oxide (FeNO) was measured with a NIOX Mino and an expiration time of 6 seconds.
Highlights
Measuring patterns of volatile organic compounds (‘VOCs’) in exhaled breath is a novel metabolomic non-invasive approach to study molecular signatures of respiratory disease
Asthmatic children that are uncontrolled despite inhaled corticosteroids have a distinct breathprint
Aim to study whether controlled and uncontrolled asthmatic children treated with inhaled corticosteroids (ICS) can be identified according to their breathprint
Summary
Asthmatic children that are uncontrolled despite inhaled corticosteroids have a distinct breathprint (the pacman study). Susanne Vijverberg1*, Paul Brinkman, Jan Raaijmakers, Kors van der Ent, Peter Sterk, Anke-Hilse Maitland-van der Zee, Leo Koenderman. From 2nd International Severe Asthma Forum (ISAF) Athens, Greece. From 2nd International Severe Asthma Forum (ISAF) Athens, Greece. 13-15 November 2014
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.